Cargando…

Diabetes mellitus: relation between cardiovascular events and pharmacological treatment

BACKGROUND AND AIM: Cardiovascular diseases are characterized by problems affecting the circulatory system, specifically the heart and blood vessels. This study evaluates the relationship between cardiovascular events and pharmacological treatment for Type II Diabetes Mellitus (T2DM). METHODS: We re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Santos, Cláudio, Brito-Costa, Sónia, Margalho, Luis, Monteiro, Pedro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Mattioli 1885 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10210556/ https://www.ncbi.nlm.nih.gov/pubmed/37092639 http://dx.doi.org/10.23750/abm.v94i2.13685

Ejemplares similares

Associations between migraine and major cardiovascular events in type 2 diabetes mellitus
por: Cheon, Dae Young, et al.
Publicado: (2022)

Risk of Cardiovascular Events in Patients With Diabetes Mellitus on β-Blockers
por: Tsujimoto, Tetsuro, et al.
Publicado: (2017)

Association between Type 1 Diabetes Mellitus and Periodontal Diseases
por: Costa, Rosana, et al.
Publicado: (2023)

Non-pharmacological Treatment Options in the Management of Diabetes Mellitus
por: Raveendran, Arkiath V, et al.
Publicado: (2018)

Pharmacokinetics and Pharmacological Activities of Berberine in Diabetes Mellitus Treatment
por: Han, Yunfeng, et al.
Publicado: (2021)

Potential Alteration of Statin-Related Pharmacological Features in Diabetes Mellitus
por: Mashayekhi-Sardoo, Habibeh, et al.
Publicado: (2021)

Early cardiovascular events in women with a history of gestational diabetes mellitus
por: Goueslard, Karine, et al.
Publicado: (2016)

Interaction between smoking and diabetes in relation to subsequent risk of cardiovascular events
por: Yang, Yang, et al.
Publicado: (2022)

Relationship between Proinflammatory and Antioxidant Proteins with the Severity of Cardiovascular Disease in Type 2 Diabetes Mellitus
por: García-Fontana, Beatriz, et al.
Publicado: (2015)

Pharmacologic Treatment Strategies in Children with Type 2 Diabetes Mellitus
por: Urakami, Tatsuhiko, et al.
Publicado: (2013)

Novel pharmacological therapy in type 2 diabetes mellitus with established cardiovascular disease: Current evidence
por: Pozo, Leonardo, et al.
Publicado: (2019)

Cardiovascular diseases or type 2 diabetes mellitus and chronic airway diseases: mutual pharmacological interferences
por: Cazzola, Mario, et al.
Publicado: (2023)

Aspirin effect on the incidence of major adverse cardiovascular events in patients with diabetes mellitus: a systematic review and meta-analysis
por: Butalia, Sonia, et al.
Publicado: (2011)

Cardiovascular events associate with diabetes status rather than with early basal insulin treatment for the prevention of post-transplantation diabetes mellitus
por: Topitz, David, et al.
Publicado: (2019)

Pharmacological Treatment in Diabetes Mellitus Type 1 – Insulin and What Else?
por: Otto-Buczkowska, Ewa, et al.
Publicado: (2017)

Novel Biomarkers to Improve the Prediction of Cardiovascular Event Risk in Type 2 Diabetes Mellitus
por: van der Leeuw, Joep, et al.
Publicado: (2016)

Empagliflozin and Cerebrovascular Events in Patients With Type 2 Diabetes Mellitus at High Cardiovascular Risk
por: Zinman, Bernard, et al.
Publicado: (2017)

SAT-545 Diabetes Mellitus Is the Risk Factor of Cardiovascular and Cerebrovascular Events in Primary Aldosteronism
por: Otsuki, Michio, et al.
Publicado: (2020)

Living Alone Is Not Associated With Cardiovascular Events and Hypoglycemia in Patients With Type 2 Diabetes Mellitus
por: Zhu, Zhaowei, et al.
Publicado: (2022)

Impact of Post-Transplant Diabetes Mellitus on Survival and Cardiovascular Events in Kidney Transplant Recipients
por: Jeon, Ja Young, et al.
Publicado: (2023)

Network pharmacology of bioactives from Sorghum bicolor with targets related to diabetes mellitus
por: Oh, Ki Kwang, et al.
Publicado: (2020)

Gestational diabetes mellitus and the role of intercurrent type 2 diabetes on long-term risk of cardiovascular events
por: Sun, Jiyu, et al.
Publicado: (2021)

Diabetes Mellitus and Cardiovascular Disease
por: Aganovic, Izet
Publicado: (2003)

Residual Risk Factors to Predict Major Adverse Cardiovascular Events in Atherosclerotic Cardiovascular Disease Patients with and without Diabetes Mellitus
por: Lin, Fang-Ju, et al.
Publicado: (2017)

The Relationships between Gut Microbiota and Diabetes Mellitus, and Treatments for Diabetes Mellitus
por: Craciun, Cristian-Ioan, et al.
Publicado: (2022)

Diabetes Mellitus and Mortality after Acute Coronary Syndrome as a First or Recurrent Cardiovascular Event
por: Cubbon, Richard M., et al.
Publicado: (2008)

Mild to moderate chronic kidney disease and cardiovascular events in patients with type 2 diabetes mellitus
por: Lessey, Gayatri, et al.
Publicado: (2019)

Data on the impact of peripheral artery disease and of type 2 diabetes mellitus on the risk of cardiovascular events
por: Saely, Christoph H., et al.
Publicado: (2018)

Urine High-Sensitivity Troponin I Predict Incident Cardiovascular Events in Patients with Diabetes Mellitus
por: Chen, Ju-Yi, et al.
Publicado: (2020)

Assessment of QRISK3 as a predictor of cardiovascular disease events in type 2 diabetes mellitus
por: Mu, Xiaodie, et al.
Publicado: (2022)

Risk Factors, Use of Preventive Drugs, and Cardiovascular Events in Diabetes Mellitus: The PURE Türkiye Cohort
por: Oğuz, Aytekin, et al.
Publicado: (2023)

Influence of Periodontal Disease on cardiovascular markers in Diabetes Mellitus patients
por: Pedroso, Juliana de Fatima, et al.
Publicado: (2019)

Association between glycemic control and cardiovascular events in older Japanese adults with diabetes mellitus: An analysis of the Japanese medical administrative database
por: Yokote, Koutaro, et al.
Publicado: (2021)

Pharmacological Treatment of Type-2-Diabetes and Cardiovascular Comorbidities: Differences between Undocumented Migrants and Natives in Italy
por: Fiorini, Gianfrancesco, et al.
Publicado: (2022)

Cardiovascular Disease in Type 1 Diabetes Mellitus: Epidemiology and Management of Cardiovascular Risk
por: Colom, Cristina, et al.
Publicado: (2021)

Noninsulin pharmacological management of type 1 diabetes mellitus
por: Garg, Vishvas
Publicado: (2011)

Tibetan Medicine for Diabetes Mellitus: Overview of Pharmacological Perspectives
por: Yan, Li-Shan, et al.
Publicado: (2021)

Kynurenine Pathway in Diabetes Mellitus—Novel Pharmacological Target?
por: Kozieł, Kamila, et al.
Publicado: (2023)

Pharmacological approaches to the prevention of type 2 diabetes mellitus
por: Majety, Priyanka, et al.
Publicado: (2023)

Association between non-pharmacological therapy and healthcare use and expenditure of patients with diabetes mellitus
por: Alfaifi, Abdullah
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_0vjnni9g40ftlm3v8849ck1k0c